This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kudo, Y.
Right arrow Articles by Pagano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kudo, Y.
Right arrow Articles by Pagano, M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2004, p. 8184-8194, Vol. 24, No. 18
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.18.8184-8194.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Role of F-Box Protein ßTrcp1 in Mammary Gland Development and Tumorigenesis

Yasusei Kudo ,1,{dagger},{ddagger} Daniele Guardavaccaro,1,{dagger} Patricia G. Santamaria,1 Ryo Koyama-Nasu,1 Esther Latres,1,§ Roderick Bronson,2 Lili Yamasaki,3 and Michele Pagano1*

Department of Pathology and NYU Cancer Institute, New York University School of Medicine,1 Biological Sciences, Columbia University, New York, New York,3 Tufts University School of Veterinary Medicine, North Grafton, Massachusetts2

Received 22 April 2004/ Returned for modification 27 May 2004/ Accepted 23 June 2004

The F-box protein ßTrcp1 controls the stability of several crucial regulators of proliferation and apoptosis, including certain inhibitors of the NF-{kappa}B family of transcription factors. Here we show that mammary glands of ßTrcp1–/– female mice display a hypoplastic phenotype, whereas no effects on cell proliferation are observed in other somatic cells. To investigate further the role of ßTrcp1 in mammary gland development, we generated transgenic mice expressing human ßTrcp1 targeted to epithelial cells under the control of the mouse mammary tumor virus (MMTV) long terminal repeat promoter. Compared to controls, MMTV ßTrcp1 mammary glands display an increase in lateral ductal branching and extensive arrays of alveolus-like protuberances. The mammary epithelia of MMTV ßTrcp1 mice proliferate more and show increased NF-{kappa}B DNA binding activity and higher levels of nuclear NF-{kappa}B p65/RelA. In addition, 38% of transgenic mice develop tumors, including mammary, ovarian, and uterine carcinomas. The targeting of ßTrcp1 to lymphoid organs produces no effects on these tissues. In summary, our results support the notion that ßTrcp1 positively controls the proliferation of breast epithelium and indicate that alteration of ßTrcp1 function and expression may contribute to malignant behavior of breast tumors, at least in part through NF-{kappa}B transactivation.


* Corresponding author. Mailing address: Department of Pathology, MSB 599, NYU School of Medicine, 550 First Ave., New York, NY 10016. Phone: (212) 263-5332. Fax: (212) 263-5107. E-mail: michele.pagano{at}med.nyu.edu.

{dagger} Y.K. and D.G. contributed equally to this work.

{ddagger} Present address: Department of Oral Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.

§ Present address: Regeneron Pharmaceuticals, Tarrytown, N.Y.


Molecular and Cellular Biology, September 2004, p. 8184-8194, Vol. 24, No. 18
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.18.8184-8194.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Crosetto, N., Bienko, M., Dikic, I. (2006). Ubiquitin Hubs in Oncogenic Networks. Mol Cancer Res 4: 899-904 [Abstract] [Full Text]  
  • Chen, C., Seth, A. K., Aplin, A. E. (2006). Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer. Mol Cancer Res 4: 695-707 [Abstract] [Full Text]  
  • Tang, W., Li, Y., Yu, D., Thomas-Tikhonenko, A., Spiegelman, V. S., Fuchs, S. Y. (2005). Targeting {beta}-Transducin Repeat-Containing Protein E3 Ubiquitin Ligase Augments the Effects of Antitumor Drugs on Breast Cancer Cells. Cancer Res. 65: 1904-1908 [Abstract] [Full Text]  
  • Jin, J., Cardozo, T., Lovering, R. C., Elledge, S. J., Pagano, M., Harper, J. W. (2004). Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 18: 2573-2580 [Full Text]